ByTrending Posts
How Peerbridge Health’s AI-Powered Cardiac Wearable Clinched the…
Key Highlights AI-Driven Innovation Revolutionizing Cardiac Diagnostics: Peerbridge Health’s Peerbridge Cor® is the first AI-powered wearable bringing hospital-grade…
How Xsolis’ AI-Driven Dragonfly Clinched the 2025 MedTech’s…
Key Highlights Xsolis Sets New Standard in AI-Powered Clinical EfficiencyTennessee-based AI tech firm Xsolis has won top honors…
25 AI-Driven Companies Leading, Top the 2025 Transformation:…
Key Highlights AI-First Innovation Is No Longer Optional—It’s the Industry Standard The 2025 MedTech leaderboard showcases how artificial…
How AccurKardia’s Award-Winning AccurECG™ Platform Redefine ECG Diagnostics…
Key Highlights: A Landmark Recognition for a Game-Changing ECG Technology AccurKardia’s AccurECG™ has been named the “Best New…
Can MIT and Recursion’s New AI Model Boltz-2…
Key Takeaways• Boltz-2 delivers AI-driven binding affinity predictions 1000x faster than traditional free energy methods—dramatically accelerating virtual screening…
Is Optic and Mechanica’s AI Venture Model the…
Key Highlights Strategic Collaboration to Power AI-Led Biotech GrowthOptic, Inc., a pioneer in AI platforms for biopharma, has…
Is the OBI Pharma–TegMine Therapeutics ADC Deal the…
Key Highlights 1. Powering the Next-Gen ADC Revolution: OBI’s GlycOBI® Meets TegMine’s TegMiner™The collaboration between Taiwan-based OBI Pharma…
Can AI Reveal the Hidden Biology of Cancer?…
Key Highlights: AI Collaboration to Decode Cancer ComplexityIn a bold step to redefine cancer treatment, Aitia, a leader…
Is Juvenescence’s Acquisition of Ro5 the Key to…
Key Insights Juvenescence Acquires Ro5 to Bolster AI Capabilities in Drug DiscoveryJuvenescence Limited, a clinical-stage AI-enabled biotech company,…
Trending Posts
Latest Stories
Is XtalPi Emerging as Pharma’s AI Engine for Molecular Property Prediction and Manufacturability at Scale?
Strategic Overview XtalPi is carving out a differentiated position in the AI-biopharma landscape by focusing…
Is Owkin Building the Clinical Data Intelligence Layer as Pharma Commits Over $1.5 Billion to Federated AI Partnerships?
Strategic Overview Owkin is positioning itself at the center of a critical bottleneck in drug…
Is Isomorphic Labs Becoming Pharma’s Foundational AI Platform as Partnerships Surpass $3 Billion and Alphabet Commits $600 Million?
Strategic Overview Isomorphic Labs is emerging as one of the most structurally important AI companies…
Is Exscientia Setting the Financial Benchmark for AI Drug Discovery with $6B+ in Pharma Commitments?
Strategic Insights Exscientia has emerged as one of the most financially validated AI-drug discovery companies,…
Gallery
